Institute for OneWorld Health Receives Multimillion Dollar Grant To Create Innovative And Sustainable Disease Control Program; $30 Million Bill & Melinda Gates Foundation Grant Aims To Greatly Reduce VL Deaths

SAN FRANCISCO--(BUSINESS WIRE)--Dec. 1, 2005--The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., today announced that it has received a US$30 million grant from the Bill & Melinda Gates Foundation to initiate and evaluate the impact of a pilot program to dramatically reduce morbidity and mortality from visceral leishmaniasis (VL) in the rural communities of India, Bangladesh, and Nepal.

MORE ON THIS TOPIC